Literature DB >> 11867079

Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains.

Eizo Iseki1, Noriko Takayama, Wami Marui, Kenji Uéda, Kenji Kosaka.   

Abstract

Using tau immunohistochemistry and alpha-synuclein immunohistochemistry, we quantitatively investigated the most frequent sites and the formation process of neurofibrillary tangles (NFT) and Lewy bodies (LB) in the hippocampus from 20 patients with dementia with Lewy bodies (DLB). NFT were most frequently found in the CA2 and the subiculum-pre-CA1, while LB were most frequently found in the CA3-4 and the subiculum-pre-CA1. In the intrahippocampal routes of the perforant pathway, tau immunoelectron microscopy demonstrated distal axons containing aggregated tau-positive microtubules, while alpha-synuclein immunoelectron microscopy revealed terminal axons containing aggregated alpha-synuclein-positive tubular or filamentous components. These findings suggest that NFT and LB are first formed in the CA2 and the CA3-4 related to degeneration of the nonperforating route of the perforant pathway, respectively, and subsequently in the subiculum-pre-CA1 chiefly related to degeneration of the perforating route. Coexistence of NFT and LB in the same neurons was found most frequently in the subiculum-pre-CA1. In addition, coexistence of tau and alpha-synuclein was found in terminal axons of the perforant pathway, and tau accumulated not in paired helical filaments but in the periphery of alpha-synuclein-positive components immunoelectron-microscopically, suggesting that alpha-synuclein stimulates the accumulation of phosphorylated tau in terminal axons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867079     DOI: 10.1016/s0022-510x(01)00689-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.

Authors:  David J Lin; Katherine L Hermann; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

2.  Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.

Authors:  Hirotake Uchikado; Wen-Lang Lin; Michael W DeLucia; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2006-07       Impact factor: 3.685

3.  Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.

Authors:  David H Adamowicz; Subhojit Roy; David P Salmon; Douglas R Galasko; Lawrence A Hansen; Eliezer Masliah; Fred H Gage
Journal:  J Neurosci       Date:  2016-12-30       Impact factor: 6.167

Review 4.  Potential mechanisms and implications for the formation of tau oligomeric strains.

Authors:  Julia E Gerson; Amrit Mudher; Rakez Kayed
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

Review 5.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

6.  TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.

Authors:  Maxime Wc Rousseaux; Maria de Haro; Cristian A Lasagna-Reeves; Antonia De Maio; Jeehye Park; Paymaan Jafar-Nejad; Ismael Al-Ramahi; Ajay Sharma; Lauren See; Nan Lu; Luis Vilanova-Velez; Tiemo J Klisch; Thomas F Westbrook; Juan C Troncoso; Juan Botas; Huda Y Zoghbi
Journal:  Elife       Date:  2016-10-25       Impact factor: 8.140

7.  Ceftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies.

Authors:  Ying-Jui Ho; Jun-Cheng Weng; Chih-Li Lin; Mei-Shiuan Shen; Hsin-Hua Li; Wen-Chieh Liao; Nu-Man Tsai; Ching-Sui Hung; Te-Jen Lai; I-Yen Lee
Journal:  Behav Neurol       Date:  2018-08-01       Impact factor: 3.342

8.  Use of Ceftriaxone in Treating Cognitive and Neuronal Deficits Associated With Dementia With Lewy Bodies.

Authors:  Ying-Jui Ho; Mei-Shiuan Shen; Chun-Hwei Tai; Hsin-Hua Li; Jian-Horng Chen; Wen-Chieh Liao; Pai-Yi Chiu; I-Yen Lee; Chih-Li Lin; Ching-Sui Hung
Journal:  Front Neurosci       Date:  2019-05-24       Impact factor: 4.677

Review 9.  Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk.

Authors:  Rakez Kayed; Ulf Dettmer; Sylvain E Lesné
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

10.  Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies.

Authors:  Sonja Fixemer; Corrado Ameli; Gaël Hammer; Luis Salamanca; Oihane Uriarte Huarte; Chantal Schwartz; Jean-Jacques Gérardy; Naguib Mechawar; Alexander Skupin; Michel Mittelbronn; David S Bouvier
Journal:  Acta Neuropathol Commun       Date:  2022-03-16       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.